Jentadueto: new combination tablet for type II diabetes

Jentadueto (linagliptin/metformin) is a new fixed-dose combination tablet for patients with type II diabetes inadequately controlled by diet and exercise.

by
Jentadueto is a new single-tablet treatment option for type II diabetes, taken twice daily.
Jentadueto is a new single-tablet treatment option for type II diabetes, taken twice daily.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package